[Utilization of hemopoietic cytokines].
Malugani
Fabio
F
Unità di Citofluorimetria e Terapie Cellulari, Oncologia Medica, Università e IRCCS San Matteo, Pavia.
Danova
Marco
M
D000818:Animals; D002864:Chromogranins; D016207:Cytokines / Q000494:pharmacology*; D000069585:Filgrastim; D019205:GTP-Binding Protein alpha Subunits, Gs; D016179:Granulocyte Colony-Stimulating Factor / Q000494:pharmacology; D006412:Hematopoietic Stem Cells / Q000187:drug effects*; D006801:Humans; D017370:Interleukin-11 / Q000494:pharmacology; D008565:Membrane Proteins / Q000494:pharmacology; D009369:Neoplasms / Q000188:drug therapy* / Q000378:metabolism; D009419:Nerve Tissue Proteins / Q000494:pharmacology; D011994:Recombinant Proteins; D019089:Stem Cell Factor / Q000494:pharmacology; D013926:Thrombopoietin / Q000494:pharmacology
D002864:Chromogranins; D016207:Cytokines; D017370:Interleukin-11; D008565:Membrane Proteins; D009419:Nerve Tissue Proteins; D011994:Recombinant Proteins; D019089:Stem Cell Factor; C084881:flt3 ligand protein; D016179:Granulocyte Colony-Stimulating Factor; D013926:Thrombopoietin; C406732:GNAS protein, human; D019205:GTP-Binding Protein alpha Subunits, Gs; D000069585:Filgrastim